fda d.i.s.c.o. burst edition: enhertu (fam-trastuzumab deruxtecan-nxki ) and combination of opdiv...

Published 6 months ago • 78 plays • Length 4:31

Download video MP4
Download video MP3

Similar videos

7:01

fda d.i.s.c.o. burst edition: fda approvals of enhertu (fam-trastuzumab deruxtecan-nxki) for unr...
4:31

fda d.i.s.c.o. burst edition: fda approval of enhertu (fam-trastuzumab deruxtecan-nxki) for adult...
7:01

fda d.i.s.c.o. burst edition: fda approvals of tabrecta (capmatinib) for metastatic non-small cel...
3:01

fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) in combination with trastu...
24:38

stage 4 matastatic her 2 positive breast cancer third line enhertu and fourth line of treatment
1:43

day 4 on first does of enhertu
5:29

breast cancer breakthroughs: antibody drug conjugates
5:31

fda d.i.s.c.o. burst edition: fda approvals of imjudo (tremelimumab) in combination with durvalum...
4:01

fda d.i.s.c.o. burst edition: fda approves a new dosing regimen for asparaginase erwinia chrysant...
7:01

fda d.i.s.c.o. burst edition: fda approvals of rituxan (rituximab) plus chemotherapy for pediatri...
5:01

fda d.i.s.c.o. burst edition: fda approvals of erbitux (cetuximab) for k-ras wild type, egfr-expr...
3:50

fda approves fam-trastuzumab deruxtecan-nxki for her2 positive gastric adenocarcinomas
0:58

enhertu therapy: a powerful new cancer treatment
1:33

breast cancer: two new drugs for her2
0:47

dr. yee on neoadjuvant pertuzumab in her2-positive breast cancer
4:52

emilia trial: t-dm1 in metastatic breast cancer
1:31

dr. vidal on potential of [fam-] trastuzumab deruxtecan in her2 breast cancer
7:45

trastuzumab emtansine in her2 breast cancer
2:37

remarkable data: trastuzumab deruxtecan for her2 bc
1:21

dr. park on the benefit of trastuzumab deruxtecan in her2 breast cancer
9:41

gracecast- asco lung 2020- enhertu and the potential for treatment of her2 positive nsclc

Clip.africa.com - Privacy-policy